Importance of medication reconciliation in cancer patients

Abstract Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can lead to dire outcomes. This commentary aims to describe the significance of conduct...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, Cindy Xin Wen
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Medication reconciliation Oncology Cancer Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/069a55c7c5d64dfebdffc243b0d7e408
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:069a55c7c5d64dfebdffc243b0d7e408
record_format	dspace
spelling	oai:doaj.org-article:069a55c7c5d64dfebdffc243b0d7e4082021-12-05T12:04:04ZImportance of medication reconciliation in cancer patients10.1186/s40545-021-00379-82052-3211https://doaj.org/article/069a55c7c5d64dfebdffc243b0d7e4082021-11-01T00:00:00Zhttps://doi.org/10.1186/s40545-021-00379-8https://doaj.org/toc/2052-3211Abstract Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can lead to dire outcomes. This commentary aims to describe the significance of conducting medication reconciliations in this often-forgotten patient population. We discuss additional clinical interventions that can arise during this process as well. Medication reconciliations provide the opportunity to identify and prevent drug–drug and herb–drug interactions. They also provide an opportunity to appropriately adjust chemotherapy dosing according to renal and hepatic function. Finally, reconciling medications can also provide an opportunity to identify and deprescribe inappropriate medications. While clinical impact appears evident in this landscape, evidence of economic impact is lacking. As more cancer patients are prescribed a combination of oral chemotherapies, intravenous chemotherapies and non-anticancer medications, future studies should evaluate the advantages of conducting medication reconciliations in these patient populations across multiple care settings.Ali ElbeddiniAnthony ToYasamin TayefehchamaniCindy Xin WenBMCarticleMedication reconciliationOncologyCancerTherapeutics. PharmacologyRM1-950Pharmacy and materia medicaRS1-441ENJournal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medication reconciliation Oncology Cancer Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441
spellingShingle	Medication reconciliation Oncology Cancer Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441 Ali Elbeddini Anthony To Yasamin Tayefehchamani Cindy Xin Wen Importance of medication reconciliation in cancer patients
description	Abstract Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can lead to dire outcomes. This commentary aims to describe the significance of conducting medication reconciliations in this often-forgotten patient population. We discuss additional clinical interventions that can arise during this process as well. Medication reconciliations provide the opportunity to identify and prevent drug–drug and herb–drug interactions. They also provide an opportunity to appropriately adjust chemotherapy dosing according to renal and hepatic function. Finally, reconciling medications can also provide an opportunity to identify and deprescribe inappropriate medications. While clinical impact appears evident in this landscape, evidence of economic impact is lacking. As more cancer patients are prescribed a combination of oral chemotherapies, intravenous chemotherapies and non-anticancer medications, future studies should evaluate the advantages of conducting medication reconciliations in these patient populations across multiple care settings.
format	article
author	Ali Elbeddini Anthony To Yasamin Tayefehchamani Cindy Xin Wen
author_facet	Ali Elbeddini Anthony To Yasamin Tayefehchamani Cindy Xin Wen
author_sort	Ali Elbeddini
title	Importance of medication reconciliation in cancer patients
title_short	Importance of medication reconciliation in cancer patients
title_full	Importance of medication reconciliation in cancer patients
title_fullStr	Importance of medication reconciliation in cancer patients
title_full_unstemmed	Importance of medication reconciliation in cancer patients
title_sort	importance of medication reconciliation in cancer patients
publisher	BMC
publishDate	2021
url	https://doaj.org/article/069a55c7c5d64dfebdffc243b0d7e408
work_keys_str_mv	AT alielbeddini importanceofmedicationreconciliationincancerpatients AT anthonyto importanceofmedicationreconciliationincancerpatients AT yasamintayefehchamani importanceofmedicationreconciliationincancerpatients AT cindyxinwen importanceofmedicationreconciliationincancerpatients
_version_	1718372235619598336

Importance of medication reconciliation in cancer patients

Ejemplares similares